X

Xeraya Capital

19 employees

Xeraya Capital is a private equity and venture capital firm.

Investor insights

Sectors invested in

Biotechnology17
Health Care8
Therapeutics6
Manufacturing5
Medical Device4
Life Science4
Medical4
Health Diagnostics3
Rapid automated detection and enumeration2
Pharmaceutical2
Quality Control Automation2
Rapid Environmental Monitoring2
Quality Control Microbiology2
Rapid Water and Bioburden Testing2
Agriculture2
AgTech2
Biopharma2
Chemical2
Renewable Energy2
Atrial fibrillation2

Funding rounds participated in

$33M sweet spot round size

Most of their 22 investments are in rounds between $14M and $60M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Healthcare Biotech
Biorenewable & Bioindustrial
Life Sciences
Private Equity
Financial Services
Medical Technologies
Venture Capital

Date founded

2012

Investments made

G

GreenLight Biosciences, Inc. raised $126M on February 3, 2022

Investors: Pura Vida Investments, S2G Ventures, Morningside Venture Capital 晨兴资本, Spruce Capital Partners, LLC and Xeraya Capital

O

OncoMyx Therapeutics raised $50M on December 9, 2021

Investors: Delos Capital, Korea Investment Partners, LYZZ CAPITAL, City Hill Ventures, Madison Partners, Lumira Ventures, B Capital Group and Xeraya Capital

U

Undisclosed raised $50M on December 8, 2021

Investors: Delos Capital, Korea Investment Partners, B Capital Group, Lumira Ventures, LYZZ CAPITAL, Madison Partners, City Hill Ventures and Xeraya Capital

I

Imago BioSciences, Inc. raised $80M on November 19, 2020

Investors: Omega Funds, Greenspring Associates, Kingdon Capital Management, Irving Investors, Surveyor Capital, T. Rowe Price and Xeraya Capital

I

InterVenn Biosciences raised $34M on November 16, 2020

Investors: Amplify Partners, Anzu Partners, True Ventures, Genoa Ventures and Xeraya Capital

C

Congenica raised $50M on November 9, 2020

Investors: Cambridge Innovation Capital plc, Future Planet Capital, 普华资本, IDO Investments - Oman Investment Authority, Parkwalk Advisors, Tencent and Xeraya Capital

R

Rapid Micro Biosystems raised $120M on May 20, 2020

Investors: Longitude Capital, Asahi KASEI Medical Europe GmbH, Endeavour Vision and Xeraya Capital

G

GreenLight Biosciences, Inc. raised $17M on May 12, 2020

Investors: Flu Lab and Xeraya Capital

A

Aria CV, Inc. raised $31M on February 25, 2020

Investors: Frontcourt Group, Catalyst Health Ventures, Brightstone Venture Capital, BioStar Ventures, Longview Ventures and Xeraya Capital

P

P2 Science, Inc. raised $12M on January 29, 2020

Investors: HG Ventures, Ironwood Capital, Elm Street Ventures, CHANEL, Advantage Capital and Xeraya Capital

FAQ